NCT07020494

A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems

A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Enzymedica · Industry
• Sex: All
• Age: 30 Years – 79 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to investigate the efficacy and safety of Lipase Thera-blend and Lipase Thera-blend + tributyrin on memory in healthy adults with self-reported memory problems. The main question\[s\] it aims to answer \[is/are\]: Does of Lipase Thera-blend improve memory in healthy adults? Does Lipase Thera-blend + tributyrin improve memory in healthy adults? Researchers will compare Lipase Thera-blend and Lipase Thera-blend + tributyrin against a placebo to see if the investigational products improve memory parameters. Participants will be asked to consume either placebo, Lipase Thera-blend, or Lipase Thera-blend + tributyrin and asked to complete memory questionnaires to assess memory.

Conditions

• Self-reported Memory Problems
• Memory

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Lipase Thera-blend	Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.
DIETARY_SUPPLEMENT	Lipase Thera-blend + tributyrin	Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.
OTHER	Placebo	Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

Timeline

• Start date: 2025-08-25
• Primary completion: 2026-02-13
• Completion: 2026-02-13
• First posted: 2025-06-13
• Last updated: 2026-03-31

Locations

1 site across 1 country: Canada